Results for "HDA Factbook"
HDA Statement on FDA's Proposed National Standards for Licensure of Distributors and 3PLs
The Healthcare Distribution Alliance (HDA) released the following statement on the U.S. Food and Drug Administration’s (FDA) proposed national licensure standards for distributors and third-party logistics providers (3PLs). HDA recently submitted public comments to FDA on the agency’s proposed standards, which are required to be established under the 2013 Drug Supply Chain Security Act (DSCSA).
HDA Research Foundation Announces 2022–2023 Karen J. Ribler Supply Chain Scholars
The HDA Research Foundation today announced the four recipients of its graduate-level Karen J. Ribler Scholarship.
HDA Urges FDA To Adopt Alternatives to Broad DSCSA Enforcement Discretion
The Healthcare Distribution Alliance (HDA) urged the Food and Drug Administration (FDA) to avoid delaying certain requirements for manufacturers and repackagers to comply with the November 27, 2023, Drug Supply Chain Security Act (DSCSA) deadline, in public comments submitted to the agency.
HDA Statement on FDA Enforcement Discretion for the DSCSA’s Final Implementation Requirements
The Healthcare Distribution Alliance (HDA) released a statement from President and CEO Chester “Chip” Davis, Jr., on the Food and Drug Administration’s (FDA) announcement that it plans to exercise enforcement discretion for the Drug Supply Chain Security Act’s (DSCSA) final implementation requirements.
HDA Presents 2026 Distribution Management Award to Cardinal Health
The Healthcare Distribution Alliance (HDA) today presented the 2026 Distribution Management Award to Cardinal Health™, recognizing the company’s leadership in advancing Drug Supply Chain Security Act (DSCSA) implementation across the pharmaceutical supply chain.